Furthermore, the study predicts microRNAs and small molecule drugs targeting CCT2-related genes, suggesting low CCT2 expression contributes to autophagy suppression in AD, thereby elucidating its pathogenesis and revealing novel therapeutic targets and inhibitors. The gene discussed is CCT2; the disease is Alzheimer disease.